Bio-identical hormones, peptide therapies, and sterile vitamin and mineral preparations to treat nutritional deficiencies
Hepatic steatosis can be reliably identified noninvasively through imaging tests, including ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI)
This approach enables more granular dosing decisions and nutritional guidance tailored to individual metabolic risk
Additional pharmacology data is available via the National Institutes of Health and FDA drug approvals database
PlexusDx Precision Peptide Genetic Test ($99 add-on) identifies your GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 variants, predicting whether you'll be a rapid or gradual responder
Book a Consultation Today